JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. enters KAILERA THERAPEUTICS, INC. with 1.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 4/17/2026ACC: 0001104659-26-044508
→
10% Owner
Since Apr 2026
1.00
Baseline shares
0.00
Direct ownership
0 positions
11.51M
Derivative underlying
2 instruments
1
Security positions
1.00 indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.00
Total
1.00 indirect1.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.00 | Indirect |
| Total | 1.00 | 1.00 indirect |
Derivative Holdings2
Series A-2 convertible preferred stock
DirectUnderlying security
Common Stock
Underlying shares
9.48M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A-2 convertible non-voting preferred stock
DirectUnderlying security
Common Stock
Underlying shares
2.03M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
11.51M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A-2 convertible preferred stock Direct | Common Stock | — | — | 9.48M | N/A | |
| Series A-2 convertible non-voting preferred stock Direct | Common Stock | — | — | 2.03M | N/A | |
| Total | 11.51M | 0.00 | ||||